Styron to Build New Latex Production Unit in Zhangjiagang

Styron said it plans to expand its latex capacity at its Zhangjiagang, China production facility.  The company said the projected additional capacity of latex will help to better serve the growing demand for latex in China's paper and paper board industry, which is projected to grow significantly over the next few years.

"The China market continues to show tremendous growth, and this expansion reinforces our leadership in meeting customer needs", said Chris Pappas, President and CEO of Styron LLC. "Zhangjiagang is the ideal location for Styron to expand our latex production and offerings. We've built and operated a plant on this site since 2002 and will continue to benefit from its strategic location, local resources, employees and community support."

The new unit, expected to commence production in Q4 2012, will be adjacent to Styron's existing latex manufacturing units at Zhangjiagang, and will complement Styron's other latex production facilities located in Korea, Indonesia and  Australia

Company

Styron

2030 Dow Center
48674-0001 Midland

Company contact







Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.